HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Friends Of The Earth Less Chummy With Nanotech; Sunscreen Concerns Linger

This article was originally published in The Rose Sheet

Executive Summary

Friends of the Earth says it has half a dozen reasons to be concerned about manufactured nanomaterials in products such as sunscreens and no compelling reason to offer for the use of such ingredients

You may also be interested in...



NGOs Call For Moratorium On Nanotech-Enabled Cosmetics

FDA’s guidance to the personal-care industry regarding nanomaterial use is a step in the right direction, but ultimately fails to protect consumers from potentially hazardous nanotech applications in the pipeline and on the market already, Food & Water Watch says, proposing a moratorium on nanotech-containing cosmetics.

FDA Strengthens Sunscreen Testing And Label Requirements

As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.

FDA Strengthens Sunscreen Testing And Label Requirements

As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016358

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel